CorMedix Inc. Announces Commercial and Operational Updates
BERKELEY HEIGHTS, N.J., Jan. 08, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Hospitals
SS Innovations Achieves Significant Milestones in 2023
Company’s award winning SSi Mantra surgical robotic system has completed over 550 surgeries and is clinically validated to perform more...
EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
Company reports preliminary placement results of twelve Focal One Systems, inclusive of ten capital sales LYON, France, January 8, 2024...
Landos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisation
Six Presentations Highlight Landos’ Leadership in Targeting Immunometabolic Pathways as Novel Treatments for Autoimmune Diseases with Focus on Ulcerative ColitisNEW...
OrthoPediatrics Corp. Announces Acquisition of Boston Orthotics & Prosthetics
Combined organizations have helped more than 1 million kids Expands Specialty Bracing Division with pediatric orthotic management business offering leading technology...
Healthcare Triangle, Inc. to Participate at the 2024 MUSE Executive Institute
PLEASANTON, Calif., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), a leader...
Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue
Company Also Expects Fourth Quarter 2023 Revenue Above Guidance, Announces General Availability of Augmedix GoSAN FRANCISCO, Jan. 05, 2024 (GLOBE...
Premier Orthopaedic and Hand Center Selects eClinicalWorks Cloud EHR and healow for Faster, More Efficient Workflows
eClinicalWorks Scribe and healow solutions to assist the specialty center in reducing provider burnout and maximizing savingsWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the...
i2i Population Health’s PRiZiM Earns ONC Health IT Certification from Drummond Group
FRANKLIN, Tenn.--(BUSINESS WIRE)--i2i Population Health’s PRiZiM product has achieved Office of the National Coordinator for Health Information Technology (ONC-Health IT)...
LEM Surgical AG Secures CHF 22 Million in Series B Funding to Ready Robotic System for FDA Submission
BERN, SWITZERLAND / ACCESSWIRE / January 4, 2024 / LEM Surgical AG, an innovative surgical robotics company headquartered in Bern,...
Healthcare Industry Veteran Donald M. Casey Jr. Joins Board of Directors at Cannabinoid Biotech Leader FloraWorks
Portland, Oregon--(Newsfile Corp. - January 4, 2024) - FloraWorks Holdings Inc., a leading cannabinoid biotech company, announced the appointment of...
Carebox and Gastric Cancer Foundation (GCF) Announce the GCF Clinical Trial Finder
Now patients, caregivers and healthcare professionals have an easy and effective way to search for and match with gastric cancer...
International Consortium Publishes Comprehensive Roadmap for the Clinical Implementation of OGM in Hematological Malignancy Applications
Framework was co-authored by an international consortium made up of 18 cancer researchers Publication includes researchers’ recommendations for laboratories planning...
Cloud DX Signs Contract with Health PEI to Provide Remote Patient Monitoring
Prince Edward Island will deploy Cloud DX Connected Health™ to Support Three Key Healthcare Priorities: Primary Care, Home Care and...
American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code
Obtaining a CPT PLA code marks a key milestone in securing reimbursement from federal and private payers for, and expanding...
MedMira Reports First Quarter Results FY2024
HALIFAX, NS / ACCESSWIRE / December 29, 2023 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for...
Report from the Extraordinary General Meeting of Promore Pharma AB Held on 29 December 2023
STOCKHOLM, SWEDEN / ACCESSWIRE / December 29, 2023 / Promore Pharma (STO:PROMO)(FRA:8T0) Promore Pharma AB, under change of name to...
Blue Horizon Announces CSE Approval of Change of Business and Commencement Date of Trading
Toronto, Ontario--(Newsfile Corp. - December 27, 2023) - Blue Horizon Global Capital Corp. (CSE: SENS) (CSE: BHCC) (formerly Sensor Technologies...
60 Degrees Pharma Announces IRB Approval of Phase IIA Study to Evaluate Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease; Type C Meeting Re-Scheduled by FDA to January 17, 2024
Investigational Review Board (IRB) approval has been granted for 60 Degrees Pharma’s double-blind, placebo-controlled study to investigate tafenoquine for treatment...
Catheter Precision, Inc. Reports Third Quarter Results of Operations and Filing of Third Quarter 10-Q
FORT MILL, SC / ACCESSWIRE / December 22, 2023 / Catheter Precision, Inc. (NYSE American:VTAK) an innovative US-based medical device...